Lectures

RNA memories and secrets of inheritance and immortality

December 30,2015

RNA memories and secrets of inheritance and immortality Worms and humans share over 3 billion years of common ancestry and consequently share amazingly complex ...

Neurexins: From Synapse Function to Schizophrenia

December 30,2015

Importance of Intellectual Environment for Research Excellence: A Personal Example in the Development of Novel Technologies for Generating Human Neurons The suc...

The roles of telomeres and telomerase in cancer and aging

December 30,2015

The roles of telomeres and telomerase in cancer and aging. Telomeres, the ends of chromosomes, are composed of long stretches of short G-rich DNA repeats, coate...

Circadian Rhythms in Health and Disease C Novel Opportunities for Therapeutics in Cancer, Diabetes

December 30,2015

Circadian Rhythms in Health and Disease Novel Opportunities for Therapeutics in Cancer, Diabetes and Neuropsychiatric Disorders Most life on our planet has evol...

The Personalized Medicine Revolution: Are We Going to Cure all Diseases and at what Price?

December 30,2015

Abstract: Many important drugs such as penicillin, aspirin, or digitalis, were discovered by serendipity - some by curious researchers who accidentally noted a ...

Should Drugs be Patented?

December 25,2015

Abstract Patents have traditionally been viewed as an important safeguard of inventors investments. Moreover, pharmaceuticals have been the poster child for pat...

Success and Failure in the Biotech Industry

December 25,2015

Abstract: During my 40 year academic career in molecular biology, I have concentrated on basic research, approaching fundamental problems in diverse areas inclu...

How a small private company can help drive innovation

December 25,2015

Abstract: Almost all successful biotechnology companies started small. Some grew large, morphed into pharmaceutical companies and became major economic forces. ...

Observations on how financial engineering can improve the economics of the biotechnology industry

December 25,2015

Abstract: Private-sector discipline and incentive system is essential for an efficiently run biotechnology industry. The current private-sector financial organi...
Home | About ISSCNL | Contact Us | © ISSCNL 2017 | Connect With Us: